What’s Next in Medtech Matters to Us All

Medtech is a $900 billion industry transforming how we treat, diagnose, and prevent disease—but its innovation engine is slowing. Vikram Aggarwal, global leader of BCG’s medical technology work, explains what’s behind the slowdown and how leaders can rethink regulation, software, and talent to re-accelerate breakthroughs. Learn More: Vikram Aggarwal: BCG on Medtech: How Medtech Leaders Are Revving Up Their Innovation Engines: Chapters 00:00-01:25 Introduction/Vikram’s ‘So What’ 01:26-02:10 What is medtech? 02:11-03:46 Where are some of the most exciting innovations happening in medtech? 03:47-05:36 What areas get the most attention? 05:37-07:33 What are the barriers to innovation? 07:34-08:36 How do software and hardware innovation compare? 08:37-09:58 Software in a medical device vs software as a medical device 09:59-11:40 Is there a lag between innovation in software vs hardware? 11:41-13:41 What is the ideal innovation environment for medtech? 13:42-15:13 How do we fix the STEM skills shortage? 15:14-17:46 What will bring the most value over the next decade? 17:47-19:04 What is happening at startups vs established companies? 19:05 – 20:01 Vikram’s ‘Now What’ 20:02-20:15 Outro This podcast uses the following third-party services for analysis: Podtrac -

You can listen to What’s Next in Medtech Matters to Us All online on Radio and Podcast. Open the player on this page to stream the available audio.

What’s Next in Medtech Matters to Us All is an episode from The So What from BCG by Boston Consulting Group BCG.

This episode is 20:16 long.

This episode was published on Nov 5, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The So What from BCG when more episodes are available from the podcast feed.